KabaFusion expands footprint
By HME News Staff
Updated 10:07 AM CDT, Tue May 20, 2025
LEXINGTON, Mass. – KabaFusion has closed on the acquisition of six locations from Coram that will serve as pharmacies and ambulatory infusion suites.
The transaction will expand KabaFusion’s ability to serve a growing number of patients nationwide and strengthen its commitment to deliver high-quality patient care across a broad range of therapies, the company says.
“Our expansion will enable KabaFusion to serve a greater number of patients with superior care,” said Dr. Sohail Masood, founder and CEO of KabaFusion. “Patient demand for home and ambulatory infusion services continues to increase, and we are thrilled to open new locations to meet the needs of our patients. We will continue to partner with practitioners, physicians, manufacturers and payers to provide superior infusion services with clinical excellence.”
This acquisition will expand KabaFusion’s footprint to 32 infusion pharmacies and 19 ambulatory infusion suites, allowing the company to enter new strategic markets in Connecticut, Georgia, Oklahoma, South Carolina and Washington, and expand its existing footprint in Nevada.
KabaFusion, which is licensed to serve patients in 45 states, is a portfolio company of Novo Holdings.
Terms of the transaction were not disclosed.
-
Related: KabaFusion partners with Memorial Hermann Health System and leverages Innovalon software.
Comments